Top Suppliers:I want be here


  • DC Chemicals Limited
  • China
  • Product Name: MK-0557
  • Price: $600.0/100mg $1100.0/250mg $2200.0/1g $220.0/10ml
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

328232-95-7

328232-95-7 structure
328232-95-7 structure
  • Name: MK 0557
  • Chemical Name: N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide
  • CAS Number: 328232-95-7
  • Molecular Formula: C22H19FN4O3
  • Molecular Weight: 406.41000
  • Catalog: Signaling Pathways GPCR/G Protein Neuropeptide Y Receptor
  • Create Date: 2016-03-25 20:12:15
  • Modify Date: 2024-01-11 18:40:41
  • MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.

Name N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide
Synonyms UNII-HVE36P8422
MK-0557
1'-cyclohexane]-4'-carboxamide
MK 0557
Description MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.
Related Catalog
Target

Ki: 1.6 nM (Y5)[1]

In Vitro MK-0557 antagonizes the effects of the NPY5R-selective agonist on body-weight gain and hyperphagia in C57BL/6J mice and significantly suppresses the body-weight gain in diet-induced obese (DIO) mice. When lean mice on regular chow are switched to a medium high-fat diet (4.2 kcal/g) and treated with MK-0557 at 30 mg/kg PO QD, MK-0557 causes a 40% reduction inbody-weight gain at day 35[2].
References

[1]. Fichtner M, et al. Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2738-43.

[2]. Erondu N, et al. Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab. 2006 Oct;4(4):275-82.

Molecular Formula C22H19FN4O3
Molecular Weight 406.41000
Exact Mass 406.14400
PSA 89.34000
LogP 3.02290
Storage condition 2-8℃

~%

328232-95-7 structure

328232-95-7

Literature: Iida, Takehiko; Satoh, Hiroki; Maeda, Kenji; Yamamoto, Yuhei; Asakawa, Ken-Ichi; Sawada, Naotaka; Wada, Toshihiro; Kadowaki, Chie; Itoh, Takahiro; Mase, Toshiaki; Weissman, Steven A.; Tschaen, Dave; Krska, Shane; Volante Journal of Organic Chemistry, 2005 , vol. 70, # 23 p. 9222 - 9229

~%

328232-95-7 structure

328232-95-7

Literature: Iida, Takehiko; Satoh, Hiroki; Maeda, Kenji; Yamamoto, Yuhei; Asakawa, Ken-Ichi; Sawada, Naotaka; Wada, Toshihiro; Kadowaki, Chie; Itoh, Takahiro; Mase, Toshiaki; Weissman, Steven A.; Tschaen, Dave; Krska, Shane; Volante Journal of Organic Chemistry, 2005 , vol. 70, # 23 p. 9222 - 9229

~%

328232-95-7 structure

328232-95-7

Literature: Iida, Takehiko; Satoh, Hiroki; Maeda, Kenji; Yamamoto, Yuhei; Asakawa, Ken-Ichi; Sawada, Naotaka; Wada, Toshihiro; Kadowaki, Chie; Itoh, Takahiro; Mase, Toshiaki; Weissman, Steven A.; Tschaen, Dave; Krska, Shane; Volante Journal of Organic Chemistry, 2005 , vol. 70, # 23 p. 9222 - 9229

~%

328232-95-7 structure

328232-95-7

Literature: Iida, Takehiko; Satoh, Hiroki; Maeda, Kenji; Yamamoto, Yuhei; Asakawa, Ken-Ichi; Sawada, Naotaka; Wada, Toshihiro; Kadowaki, Chie; Itoh, Takahiro; Mase, Toshiaki; Weissman, Steven A.; Tschaen, Dave; Krska, Shane; Volante Journal of Organic Chemistry, 2005 , vol. 70, # 23 p. 9222 - 9229

~%

328232-95-7 structure

328232-95-7

Literature: MERCK and CO., INC.; BANYU PHARMACEUTICAL CO., LTD. Patent: WO2007/16028 A2, 2007 ; Location in patent: Page/Page column 13; 14 ; WO 2007/016028 A2

~17%

328232-95-7 structure

328232-95-7

Literature: Haga, Yuji; Sakamoto, Toshihiro; Shibata, Takunobu; Nonoshita, Katsumasa; Ishikawa, Makoto; Suga, Takuya; Takahashi, Hirobumi; Takahashi, Toshiyuki; Takahashi, Hidekazu; Ando, Makoto; Murai, Takashi; Gomori, Akira; Oda, Zenjun; Kitazawa, Hidefumi; Mitobe, Yuko; Kanesaka, Maki; Ohe, Tomoyuki; Iwaasa, Hisashi; Ishii, Yasuyuki; Ishihara, Akane; Kanatani, Akio; Fukami, Takehiro Bioorganic and Medicinal Chemistry, 2009 , vol. 17, # 19 p. 6971 - 6982